The nice
people at the Stem Cell Evidence Alert sent their update today. As with much of
the CPD I do it isn’t so much of direct useful relevance, but more of
background interest. But it is that background interest which is perhaps where I
need to concentrate. It’s so easy to get focussed on a very tiny aspect of a
very specialised field and to forget that what I do on a day-to-day basis is
only a tiny part of an enormous whole.
Selected new publications
Benefits and challenges with diagnosing chronic and late acute GvHD in children using the NIH consensus criteria
Cuvelier, G. D. E., Nemecek, E., et al., Blood 2019
Cuvelier, G. D. E., Nemecek, E., et al., Blood 2019
Clinical
utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell
acute lymphoblastic leukemia (ALL)-an expert opinion from the European
Society for Blood and Marrow Transplantation (EBMT) and the American
Society for Blood and Marrow Transplantation (ASBMT)
Kansagra, A. J., Frey, N. V., et al. Bone marrow transplantation 2019
Kansagra, A. J., Frey, N. V., et al. Bone marrow transplantation 2019
Response to novel drugs before and after Allogeneic Stem Cell Transplantation in Multiple Myeloma relapsing patients
Lopez-Corral, L., Velazquez, T. C., et al. Biology of blood and marrow transplantation 2019.
Lopez-Corral, L., Velazquez, T. C., et al. Biology of blood and marrow transplantation 2019.
Reduced intensity allogeneic stem cell transplantation for younger patients with myelofibrosis
Mannina, D., Zabelina, T., et al. British journal of haematology 2019
Mannina, D., Zabelina, T., et al. British journal of haematology 2019
Outcomes
of allogeneic stem cell transplantation after inotuzumab ozogamicin
treatment for relapsed or refractory acute lymphoblastic leukemia
Marks, D. I., Kebriaei, P., et al. Biology of blood and marrow transplantation 2019.
Free full text
Marks, D. I., Kebriaei, P., et al. Biology of blood and marrow transplantation 2019.
Free full text
Alternative
donor transplantation for acute myeloid leukemia in patients aged
>/=50 years: young HLA-matched unrelated or haploidentical Donor?
Perales, M. A., Tomlinson, B., et all. Haematologica 2019.
Free full text
Perales, M. A., Tomlinson, B., et all. Haematologica 2019.
Free full text
Allogeneic
hematopoietic stem cell transplantation from unrelated donors is
associated with higher infection rates in children with acute
lymphoblastic leukemia - A prospective international multicenter trial
on behalf of the BFM-SG and the EBMT-PDWP
Pichler, H., Lawitschka, A., et al. American journal of hematology 2019.
Pichler, H., Lawitschka, A., et al. American journal of hematology 2019.
Allogeneic
stem cell transplantation using HLA-matched donors for acute myeloid
leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia
Working Party of the EBMT
Poire, X., Labopin, M., et al. Haematologica 2019.
Free full text
Poire, X., Labopin, M., et al. Haematologica 2019.
Free full text
Impact of T-cell dose on the outcome of T-cell replete HLA matched allogeneic peripheral blood stem cell transplantation
Saad, A., Lamb, L., et al. Biology of blood and marrow transplantation 2019.
Saad, A., Lamb, L., et al. Biology of blood and marrow transplantation 2019.
Article of the Month: June 2019
Allogeneic
hematopoietic cell transplantation compared to chemotherapy
consolidation in older acute myeloid leukemia (AML) patients 60-75 years
in first complete remission (CR1): an alliance (A151509), SWOG,
ECOG-ACRIN, and CIBMTR study
Ustun, C., Le-Rademacher, J., et al. Leukemia 2019 Free full text |
No comments:
Post a Comment